series-b
Stage
2020
Founded
5
Investors
About
Volastra Therapeutics is a clinical-stage biotechnology company focused on developing oncology therapeutics that target chromosomal instability (CIN) in cancer cells. The company exploits vulnerabilities in chromosomally unstable cancers through synthetic lethality and immune activation approaches.
Explore Volastra Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.